KDR and neoplasm: Given that Vegfr2Cre/+ targets also hematopoietic cells16, we aimed at ruling out a possible contribution of hematopoietic Vegfr2 in tumor angiogenesis by specifically inactivating Vegfr2 in hematopoietic cells.